Invuity Announces 2018 Second Quarter Financial Results and Conference Call Date
20 Juillet 2018 - 10:01PM
Invuity, Inc. (NASDAQ:IVTY), a leading medical technology company
focused on minimal access surgery, today announced that it will
release its 2018 second quarter financial results after the market
closes on Thursday, August 2, 2018. In conjunction with the
release, the Company will host a conference call with the
investment community at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern
Time on Thursday, August 2, 2018, to discuss the financial results
and other business developments.
Interested parties may access the live call via telephone by
dialing 1-877-556-8638 (U.S.) or 1-615-247-0174 (International),
Conference ID: 2364838. To listen to the live call via Invuity's
website, go to www.invuity.com, in the Events & Presentations
section. A webcast replay of the call will be available following
the conclusion of the call in the Events & Presentations
section of the website.
About Invuity®Invuity, Inc. is a leading
medical technology company focused on developing and marketing
advanced surgical devices to improve the ability of physicians to
perform minimal access surgery through smaller and hidden
incisions. The Company’s patented Intelligent Photonics® technology
delivers enhanced visualization, which facilitates surgical
precision, efficiency and safety. Clinical applications
include women’s health, encompassing breast cancer and breast
reconstruction surgery, gynecology and thyroid surgery.
Additional applications include procedures for electrophysiology,
spine, orthopedic, cardiothoracic and general surgery. Invuity is
headquartered in San Francisco, CA.
CONTACT:Company Contact:Jim MackanessChief Financial
OfficerInvuity, Inc.415-655-2129
Investors:Mark KlausnerWestwicke
Partners443-213-0501irdept@invuity.com
INVUITY, INC. (NASDAQ:IVTY)
Graphique Historique de l'Action
De Mar 2025 à Avr 2025
INVUITY, INC. (NASDAQ:IVTY)
Graphique Historique de l'Action
De Avr 2024 à Avr 2025
Real-Time news about Invuity, Inc. (delisted) (NASDAQ): 0 recent articles
Plus d'articles sur